Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Mechanisms of Disease Progression and Renoprotective Pharmacotherapy in Children With Chronic Renal Failure

NCT00221845 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT00221845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00221845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Mechanisms of Disease Progression and Renoprotective Pharmacotherapy in Children With Chronic Renal Failure
Lead sponsor
Heidelberg University
Phase
Phase 3
Overall status
Completed
Start date
January 31, 1998
Completion date
January 31, 2010
Enrollment
400 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

acquired kidney disease, children, chronic renal failure, congenital kidney disease, hypertension